CDT Equity (CDT) Exchange Rate Effect (2023 - 2026)
CDT Equity's (CDT) quarterly Exchange Rate Effect came in at -$5000.0 in Q1 2026, up 72.22% YoY from -$2903.2 in Q1 2025, and up 82.76% on a QoQ basis from -$29000.0 in Q4 2025.
CDT Equity (CDT) Exchange Rate Effect (2023 - 2026) Analysis & Trends
CDT Equity (CDT) has 4 years of Exchange Rate Effect data on file, last reported at -$5000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 72.22% year-over-year to -$5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$91000.0 (down 1200.0% YoY) and the FY2025 annual result came in at -$104000.0, down 550.0% from the prior year.
- Exchange Rate Effect rose to -$5000.0 in Q1 2026, from -$29000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $304000.0 in Q4 2023 to a low of -$83000.0 in Q3 2025.
- A 4-year average of $13384.6 and a median of -$1000.0 in 2024 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 2700.0% in 2025, down 3000.0% in 2025.
- Tracing CDT's Exchange Rate Effect over 4 years: stood at $304000.0 in 2023, then sank by 99.67% to $1000.0 in 2024, then sank by 3000.0% to -$29000.0 in 2025, then surged by 82.76% to -$5000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$5000.0 (Q1 2026), -$29000.0 (Q4 2025), and -$83000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CDT Equity | 1.55 Mn | 1.55 Mn | - | 7,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Dec 31, 2025 | -29,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Sep 30, 2025 | -83,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Mar 31, 2024 | -27,000.00 |